Full Answer
Who buys zomedica (Zom) stock?
Apr 13, 2022 · A pandemic darling stock, Zoom (NASDAQ: ZM) is having a great day as it unveils new products. Despite recently declining more than 80% from its 52-week high, ZM stock is soaring higher today, up 8 ...
Is Zoom stock still a growth story?
Mar 31, 2022 · Zomedica's stock was trading at $0.2078 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ZOM stock has increased by 44.4% and is now trading at $0.30. View which stocks have been most impacted by COVID-19.
Where can I buy shares of Zom?
Stock was .08 and it shot up all the way to 2.7. Since then the stock did go down and it stopped this downward trend around .28c and since then it has been building the …
Will zomedica stock outperform or underperform the S&P 500 over the long term?
Apr 08, 2022 · Real-time trade and investing ideas on Zomedica Pharmaceuticals Corp ZOM from the largest community of traders and investors. ... Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. Zomedica Pharmaceuticals Corp 0.30 0.01 (3.50%) Watch. Zomedica Pharmaceuticals Corp NYSEArca Updated Apr 12, 2022 8:00 AM. ZOM 0.30 0.01 ...
Why is Zomedica stock going up?
Investors are excited about Zomedica's sales primarily because of one reason: They're growing. In the prior-year period, the company didn't generate any revenue at all. Zomedica barely had any sales during the first three quarters of 2021. The difference-maker was the company's acquisition of PulseVet last October.Feb 28, 2022
Will ZOM stock go up?
There is potential for a short term uptick in the Zom stock price, especially as the active weekly candle is mildly bullish.Feb 4, 2022
Is ZOM a good stock to buy now?
In the final analysis, ZOM stock is highly risky and best suited for speculative traders. Yet it's possible that retail traders will bid the stock up in 2022. And if they abandon Zomedica, it would be a dog-gone shame.Jan 7, 2022
What is ZOM stock prediction?
Stock Price Forecast The 1 analysts offering 12-month price forecasts for Zomedica Corp have a median target of 1.20, with a high estimate of 1.20 and a low estimate of 1.20. The median estimate represents a +253.15% increase from the last price of 0.34.
What is the future of ZOM stock?
The Zomedica Pharmaceuticals Corp stock price gained 1.96% on the last trading day (Thursday, 14th Apr 2022), rising from $0.30 to $0.31....Predicted Opening Price for Zomedica Pharmaceuticals Corp of Monday, April 18, 2022.Fair opening price April 18, 2022Current price$0.30$0.31 (Overvalued)
Why is ZOM dropping?
CEO Robert Cohen said the move was precipitated by "changes at our current distributor that we believe have impacted its ability to market our products effectively." Those words likely startled investors, many of whom decided to sell their shares. Zomedica's stock price dropped sharply on Thursday.Apr 15, 2021
Is Castor Maritime a good buy?
The Castor Maritime Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
How has Zomedica's stock been impacted by COVID-19 (Coronavirus)?
Zomedica's stock was trading at $0.2078 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organ...
When is Zomedica's next earnings date?
Zomedica is scheduled to release its next quarterly earnings announcement on Tuesday, May 10th 2022. View our earnings forecast for Zomedica .
How were Zomedica's earnings last quarter?
Zomedica Corp. (NYSEAMERICAN:ZOM) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per shar...
What guidance has Zomedica issued on next quarter's earnings?
Zomedica issued an update on its FY 2021 earnings guidance on Monday, March, 14th. The company provided earnings per share (EPS) guidance of for th...
Who are Zomedica's key executives?
Zomedica's management team includes the following people: Mr. Robert Cohen , CEO & Director (Age 63, Pay $412.79k) Ms. Ann Marie Cotter CPA , C...
Who are some of Zomedica's key competitors?
Some companies that are related to Zomedica include Protagonist Therapeutics (PTGX) , Keros Therapeutics (KROS) , Myovant Sciences (MYOV) , Axs...
What is Zomedica's stock symbol?
Zomedica trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ZOM."
Who are Zomedica's major shareholders?
Zomedica's stock is owned by a variety of retail and institutional investors. Top institutional investors include State Street Corp (2.93%), BlackR...
Which institutional investors are selling Zomedica stock?
ZOM stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Geode Capital Management LLC, Commonwealt...
Signals & Forecast
The Zomedica Pharmaceuticals Corp stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Support, Risk & Stop-loss
Zomedica Pharmaceuticals Corp finds support from accumulated volume at $0.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Zomedica Pharmaceuticals Corp stock A Buy?
Zomedica Pharmaceuticals Corp holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Retail Investors Are Piling In
In the beginning of the year, meme stocks were all the rage. GameStop, AMC, Bed Bath & Beyond, and several others made their ways to the top as retail investors dove into, squeezing the shorts out of their positions. ZOM was one of these stocks.
ZOM Beyond The Meme Stock Push
While Zomedica has found itself caught up in the meme stock frenzy, there’s much more to the company than simply retail excitement. In fact, ZOM is a company that’s working to save the lives of companion animals.
Final Thoughts
All told, investors and traders alike seem to be excited about ZOM stock. Investors are looking forward to the long-term opportunity posed by the company while traders see an opportunity to ride the wave as retailers band together to push the shorts out. At this point, if you’fe not watching the stock yet, you’re missing out!